Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.645 USD | -0.78% | -2.83% | -15.24% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.24% | 13.71M | |
+26.69% | 49.18B | |
+0.62% | 42.11B | |
+50.52% | 40.37B | |
-5.26% | 28.85B | |
+12.69% | 26.09B | |
-21.81% | 18.71B | |
+9.10% | 13.26B | |
+31.00% | 12.32B | |
-0.61% | 11.99B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics Chief Medical Officer Mark Gelder Dies Unexpectedly